Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs, NCT05459844. Registered 5 July 2022, https://clinicaltrials.gov/study/NCT05459844?cond=NCT05459844&rank=1.
Authors
- Jindian Li (ORCID: https://orcid.org/0009-0004-1113-6760)
- Fei Liu
- Jie Chen
- Jianping Zhang
- Shaoli Song
- Ying Qiao
- Hongxing Yang
Institutions
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- United Imaging Healthcare (China) (CN)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1186/s13550-026-01402-2
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00